Advertisement

Travelers and tuberculosis

Recommend a tuberculin skin test to patients returning from regions where tuberculosis is endemic.

August 8, 2000

NEW YORK, August 7 (Praxis Press) Tuberculosis remains endemic in many countries, and the risk of infection to international travelers visiting these destinations is unknown. Cobelens and colleagues studied the incidence of and risk factors for tuberculin skin test conversion among Bacille Calmette-Guérin (BCG)-naive Dutch travelers; all travelers spent three to 12 months in countries with an estimated annual risk of Mycobacterium tuberculosis infection of at least 1%. Among 656 travelers who had a negative pretravel purified protein derivative (PPD) skin test result, 1.8% had a positive posttravel PPD skin test result. Risks of infection were 7.9 and 2.8 per 1,000 person-months of travel for health-care workers and non-health-care workers, respectively. Travelers to regions where tuberculosis is endemic have a risk of infection similar to the risk of the local population; physicians should advise travelers to obtain prophylactic BCG vaccination before travel or a tuberculin skin test after travel.

Advertisement

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies